Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

Rhea-AI Summary

Haemonetics (NYSE: HAE) has scheduled the release of its first quarter fiscal year 2026 financial results for August 7, 2025 at 6:00 am ET. The company will host a conference call with investors and analysts at 8:00 am ET on the same day to discuss the results and take questions.

Participants can access the call via teleconference after completing registration, and are encouraged to join 10 minutes before the start. A live webcast will be available on Haemonetics' investor relations website, with a replay accessible for one year starting August 7, 2025, at 11:00 am ET.

News Market Reaction

+0.84%

1 alert

+0.84% News Effect

On the day this news was published, HAE gained 0.84%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, July 9, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, August 7, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on August 7, 2025.

The call can be accessed via teleconference at: Q1 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/wv7zkgdh 

A replay of the conference call and webcast will be available for one year beginning on August 7, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury     
(781) 356-9763 
olga.guyette@haemonetics.com       

David Trenk, Manager-Investor Relations
(203) 733-4987 
david.trenk@haemonetics.com                                                                                

Media Contact:   
Josh Gitelson, Sr. Director-Global Communications   
(781) 356-9776
josh.gitelson@haemonetics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2026-results-august-7-2025-302501499.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) release Q1 2026 earnings?

Haemonetics will release Q1 fiscal year 2026 earnings on August 7, 2025 at 6:00 am ET.

How can investors join the Haemonetics Q1 2026 earnings call?

Investors can join via teleconference after registration or through the live webcast on Haemonetics' investor relations website at 8:00 am ET on August 7, 2025.

Will there be a replay available for Haemonetics' Q1 2026 earnings call?

Yes, a replay of the conference call and webcast will be available for one year beginning on August 7, 2025 at 11:00 am ET.

What time should participants join the Haemonetics earnings call?

While not required, participants are recommended to join 10 minutes prior to the event start time of 8:00 am ET.